Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |